ASX health stocks fall o.92% over past five days as US President Donald Trump renews threat to impose tariffs on pharmaceutical imports.

The government will allocate the payment to affordable homes programmes across all four nations, including giving funding ...

The developer funds will be used to build "hundreds" of new affordable houses across England, Scotland, Wales and Northern ...

Here's why these Australian stocks could be among the best to buy and hold forever right now. Let's dig deeper into ...

Here's one S&P/ASX 300 Index (ASX: XKO) share that Stuart Bromley of Medallion Financial Group rates a buy and one that's a ...

IGC Pharma to Host Fiscal Year-End 2025 Shareholder Update Call on Monday June 30, 2025 Provided by ACCESS Newswire Jun 27, 2025, 12:30:00 PM ...

Arkansas will receive $44.5 million of a $7.4 billion settlement with Purdue Pharma and the Sackler family for their role in the United States’ opioid epidemic.

On this week’s episode of "The Top Line," Fierce Pharma’s Fraiser Kansteiner sits down with Francis to talk about the progress made so far on Teva’s “Pivot to Growth” strategy and what ...

Sun Pharma appoints Richard Ascroft as North America CEO to lead U.S. and Canada operations, including new drug launches and NJ HQ expansion.

China's pharma star is rising As innovative new drugs flow from China, some see an opportunity, others a threat.

US biotech Arbutus Biopharma (Nasdaq: ABUS) has reacquired the rights to its lead hepatitis B candidate, imdusiran (AB-729), in China, ending a nearly four-year partnership with Qilu Pharmaceutical.

LITTLE ROCK (KATV) — Arkansas Attorney General Tim Griffin recently announced the results of the $7.4 billion settlement with Purdue Pharma and the Sackler family for their role in the ...